Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B S Roden

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|June 28, 2011
Comparison of candidate serologic markers for type I and type II ovarian cancerDan Lu, Elisabetta Kuhn, Robert E Bristow, et al.
Gynecologic Oncology|April 29, 2009
p53 autoantibodies, cytokine levels and ovarian carcinogenesisMiyun Tsai-Turton, Antonio Santillan, Dan Lu, et al.
Cancer Research|April 6, 2006
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosisMartina Bazzaro, Michael K Lee, Alessia Zoso, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccineMichael G Berg, Robert J Adams, Ratish Gambhira, et al.
The Laryngoscope|January 9, 2024
Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory PapillomatosisBrandon Lam, Jonas Miller, Yu Jui Kung, et al.
The American Journal of Pathology|September 18, 2007
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motilityMartina Bazzaro, Antonio Santillan, Zhenhua Lin, et al.
Plos One|November 10, 2011
Capsomer vaccines protect mice from vaginal challenge with human papillomavirusWai-Hong Wu, Elizabeth Gersch, Kihyuck Kwak, et al.
Vaccine|January 24, 2007
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11Katharina Slupetzky, Ratish Gambhira, Timothy D Culp, et al.
Journal of the National Cancer Institute|May 28, 2009
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccinesSubhashini Jagu, Balasubramanyam Karanam, Ratish Gambhira, et al.
Journal of Ovarian Research|January 15, 2024
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodiesHsin-Fang Tu, Margaret Wong, Ssu-Hsueh Tseng, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|June 28, 2011
Comparison of candidate serologic markers for type I and type II ovarian cancerDan Lu, Elisabetta Kuhn, Robert E Bristow, et al.
Gynecologic Oncology|April 29, 2009
p53 autoantibodies, cytokine levels and ovarian carcinogenesisMiyun Tsai-Turton, Antonio Santillan, Dan Lu, et al.
Cancer Research|April 6, 2006
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosisMartina Bazzaro, Michael K Lee, Alessia Zoso, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccineMichael G Berg, Robert J Adams, Ratish Gambhira, et al.
The Laryngoscope|January 9, 2024
Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory PapillomatosisBrandon Lam, Jonas Miller, Yu Jui Kung, et al.
The American Journal of Pathology|September 18, 2007
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motilityMartina Bazzaro, Antonio Santillan, Zhenhua Lin, et al.
Plos One|November 10, 2011
Capsomer vaccines protect mice from vaginal challenge with human papillomavirusWai-Hong Wu, Elizabeth Gersch, Kihyuck Kwak, et al.
Vaccine|January 24, 2007
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11Katharina Slupetzky, Ratish Gambhira, Timothy D Culp, et al.
Journal of the National Cancer Institute|May 28, 2009
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccinesSubhashini Jagu, Balasubramanyam Karanam, Ratish Gambhira, et al.
Journal of Ovarian Research|January 15, 2024
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodiesHsin-Fang Tu, Margaret Wong, Ssu-Hsueh Tseng, et al.
Pageof 14